articles details

Research
June 15, 2025

Aleeto® Nasal Spray (HAPPLEY®)

1)Dosage Form Characteristics:
The nasal spray leverages absorption across the nasal mucosa to bypass the blood–brain barrier, achieving high bioavailability and rapid central nervous system penetration. It is well suited for long-term management in mild to moderate cases.
2)Indications:
• Autism spectrum disorder (ASD)
• Amyotrophic lateral sclerosis (ALS)
• Post-stroke rehabilitation
• Alzheimer’s disease (AD) and other neurodegenerative disorders
3)Key Advantages:
• Convenience: Needle-free, self-administrable by patients.
• Central Targeting: Intranasal route enhances and accelerates CNS delivery.
• Chronic Disease Management: Supports maintenance therapy to improve patient quality of life.
• Reduced Systemic Burden: Localized nasal delivery minimizes hepatic and renal exposure.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Popular Post

Caring for the Elderly, Safeguarding Memory – Alzheimer’s Disease Science-Popularization Open Day Successfully Held — DarwinCell Biotech Alzheimer’s Disease Public Science Open Day
DarwinCell Showcases novel MSC-based drug ALT001 at the 150th American Neurological Association Annual Meeting
Darwin Biotech Chairwoman Yu Wang Named “Beijing March 8th Red-Banner Holder”: Illuminating New Hope for Life Through Science

Categories

  • Research Insights (02)
  • Laboratory Best Practices (04)
  • Innovation & Technology (01)
  • Industry Trends (03)
  • Sustainability in Science (05)
  • Events & Workshops (02)
  • Educational Resources (04)